Rigel Pharmaceuticals Balance Sheet (2010-2026) | RIGL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	30.40M	18.89M	24.68M	27.20M	29.87M	24.46M	40.28M	48.81M	45.41M	32.79M	25.57M	36.05M	51.69M	56.75M	45.73M	53.41M	48.53M	40.58M	24.41M	60.82M
Short-term Investments (Quarter)	112.74M	106.08M	82.84M	61.97M	51.78M	33.75M	18.38M	15.54M	16.94M	24.15M	23.98M	13.05M	9.42M	20.57M	31.37M	54.97M	88.61M	114.38M	122.27M	34.51M
Cash & Current Investments (Quarter)	143.15M	124.97M	107.52M	89.17M	81.64M	58.21M	58.66M	64.36M	62.35M	56.93M	49.55M	49.10M	61.11M	77.32M	77.10M	108.38M	137.14M	154.96M	146.68M	95.33M
Receivables - Net (Quarter)	14.99M	15.47M	15.24M	17.20M	15.53M	20.00M	29.37M	20.82M	23.55M	30.55M	27.51M	28.90M	30.57M	41.62M	3.00M	39.91M	45.92M	51.76M	49.95M	56.04M
Receivables - Other (Quarter)															0.06M	0.06M	0.06M	0.90M	1.00M	0.30M
Receivables (Quarter)	14.99M	15.47M	15.24M	17.20M	15.53M	20.00M	29.37M	20.82M	23.55M	30.55M	27.51M	28.90M	30.57M	41.62M	3.06M	39.96M	45.98M	52.66M	50.95M	56.34M
Raw Materials (Quarter)	5.14M	5.14M	4.55M	4.55M	4.55M	4.55M	6.91M	6.88M		4.61M	3.92M	2.15M	1.57M	1.08M	1.08M	9.63M	6.95M	4.51M	3.43M	7.23M
Work In Process (Quarter)	0.48M	0.16M	1.04M	0.57M	1.24M	2.66M	2.05M	2.05M		1.88M	5.12M	6.01M	1.81M	1.23M	1.11M	2.03M	5.49M	3.91M	6.23M	7.00M
Finished Goods (Quarter)	1.41M	1.31M	1.17M	1.09M	1.32M	1.90M	2.12M	1.86M		1.51M	1.27M	4.37M	5.83M	5.01M	3.76M	2.71M	1.79M	4.71M	4.10M	2.84M
Inventory (Quarter)	7.04M	6.62M	6.76M	6.22M	7.12M	9.12M	11.08M	10.78M	6.11M	5.52M	6.58M	8.06M	4.78M	6.00M	4.66M	10.42M	13.30M	11.51M	11.65M	14.37M
Prepaid Assets (Quarter)	5.93M	7.41M	9.41M	7.94M	6.16M	8.26M	7.87M	4.97M	3.02M	6.26M	8.85M	8.66M	9.99M	10.16M	6.38M	5.44M	5.86M	21.94M	25.75M	19.79M
Current Assets (Quarter)	171.10M	154.47M	138.94M	120.52M	110.44M	115.90M	106.97M	100.92M	95.02M	99.27M	92.49M	94.72M	106.47M	135.10M	146.56M	175.39M	214.93M	240.17M	234.03M	185.53M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	2.65M	2.18M	2.14M	1.83M	1.69M	0.86M	0.29M	0.21M	0.19M	0.17M	0.14M	0.12M	0.10M	0.09M	0.08M	0.06M	0.05M
Goodwill & Intangibles (Quarter)						15.00M	14.68M	14.41M	14.15M	13.88M	28.86M	28.27M	27.69M	27.10M	26.51M	25.92M	25.34M	24.75M	24.16M	93.88M
Long-Term Deferred Tax (Quarter)																		245.85M	243.28M	238.07M
Other Non-Current Assets (Quarter)	0.94M	0.97M	0.46M	0.40M	0.48M	0.64M	0.54M	0.54M	4.96M	3.06M	4.32M	4.74M	4.76M	1.53M	1.52M	4.18M	1.17M	1.91M	2.36M	2.94M
Non-Current Assets (Quarter)	15.41M	12.86M	10.14M	7.48M	5.17M	18.38M	16.64M	16.17M	20.30M	17.96M	34.03M	33.69M	32.95M	28.87M	29.41M	31.34M	27.61M	273.43M	270.58M	335.54M
Assets (Quarter)	186.52M	167.33M	149.07M	128.00M	115.61M	134.28M	123.61M	117.09M	115.32M	117.22M	126.52M	128.41M	139.42M	163.98M	175.97M	206.74M	242.53M	513.59M	504.61M	521.07M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.14M	3.79M	4.61M	2.15M	2.72M	15.00M	6.29M	5.24M	8.00M	7.14M	9.28M	6.13M	3.81M	3.34M	3.95M	7.29M	3.85M	7.19M	4.49M	4.01M
Payables (Quarter)	3.14M	3.79M	4.61M	2.15M	2.72M	15.00M	6.29M	5.24M	8.00M	7.14M	9.28M	6.13M	3.81M	3.34M	3.95M	7.29M	3.85M	7.19M	4.49M	4.01M
Accumulated Expenses (Quarter)	9.46M	10.69M	6.63M	7.53M	8.77M	8.87M	5.66M	6.74M	8.09M	8.68M	5.25M	6.37M	7.92M	10.14M	6.02M	7.90M	10.06M	11.91M	6.01M	8.61M
Other Accumulated Expenses (Quarter)	10.98M	4.78M	11.59M	16.89M	17.60M	5.00M	5.62M	5.01M	4.83M	5.33M	1.00M	5.93M	9.97M	11.75M	7.44M	8.59M	8.94M	11.47M	9.67M	7.95M
Short term Debt (Quarter)										7.23M	14.78M			7.27M	14.81M	22.36M	29.76M	29.81M	29.86M	39.24M
Current Leases (Quarter)	9.57M	9.89M	8.30M	5.81M	3.31M	1.13M	0.45M	0.47M	0.67M	0.69M	0.71M	0.64M	0.47M	0.28M	0.46M	0.52M	0.59M	0.61M	0.64M	0.66M
Current Deferred Revenue (Quarter)	3.16M	2.60M	2.10M	1.54M	1.37M	1.37M	1.37M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M	1.35M
Total Current Liabilities (Quarter)	59.28M	63.55M	59.23M	54.95M	47.27M	65.21M	45.52M	44.02M	48.27M	53.27M	73.20M	58.65M	54.31M	63.30M	66.63M	86.64M	94.40M	99.24M	89.49M	95.59M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	19.89M	19.91M	29.85M	29.84M	39.47M	39.45M	59.48M	59.57M	59.66M	52.37M	44.91M	59.69M	59.76M	59.68M	44.93M	37.45M	29.97M	52.29M	14.99M	39.24M
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)	3.31M	0.76M	8.30M			0.97M	0.80M	0.63M	0.47M	0.28M	0.10M				0.86M	0.71M	0.56M	0.40M	0.23M	0.06M
Other Non-Current Liabilities (Quarter)	54.37M	52.73M	53.20M	46.89M	48.71M	42.26M	42.06M	40.98M	38.76M	39.94M	15.22M	15.00M	5.00M	5.00M	39.98M	5.00M	5.00M
Total Non-Current Liabilities (Quarter)	132.15M	84.23M	95.87M	81.11M	66.90M	105.63M	105.80M	104.22M	108.40M	105.92M	142.97M	143.32M	149.06M	155.69M	117.42M	119.80M	119.92M	122.11M
Total Liabilities (Quarter)	186.52M	136.95M	149.07M	128.00M	115.61M	147.90M	147.87M	145.21M	147.16M	145.87M	158.19M	158.32M	154.06M	160.69M	157.41M	124.80M	124.92M	122.11M	104.71M	95.64M
Shareholder's Equity
Total Debt (Quarter)	19.89M	19.91M	29.85M	29.84M	39.47M	39.45M	59.48M	59.57M	59.66M	59.60M	59.69M	59.69M	59.76M	66.95M	59.75M	59.81M	59.73M	82.11M	44.86M	78.47M
Common Equity (Quarter)	49.67M	30.37M	6.80M	-3.68M	-19.83M	-13.62M	-24.26M	-28.11M	-31.83M	-28.64M	-31.67M	-29.91M	-14.64M	3.29M	18.57M	81.93M	117.61M	391.48M	399.90M	425.42M
Liabilities and Shareholders Equity (Quarter)	186.52M	167.33M	149.07M	128.00M	115.61M	134.28M	123.61M	117.09M	115.32M	117.22M	126.52M	128.41M	139.42M	163.98M	175.97M	206.74M	242.53M	513.59M	504.61M	521.07M
Retained Earnings (Quarter)	0.01M	-1323.89M	-0.42M	-0.44M	-1383.86M	-0.15M	-1395.99M	-1402.60M	-0.01M	0.01M	-1415.80M	-1416.83M	-1404.41M	0.01M	-0.00M	-1319.01M	-1291.11M	-1023.04M	-0.13M	-997.10M
Treasury Shares (Quarter)		0.23M	1.21M	1.19M	1.17M	1.10M	1.99M	1.96M	1.94M	0.19M	4.07M	0.39M	0.38M	0.39M	0.57M	0.57M	0.57M	0.61M	0.07M	0.97M

Research Tools

Datasets

Plans

Developers

Rigel Pharmaceuticals Balance Sheet (2010-2026) | RIGL

Research Tools

Datasets

Plans

Developers

Rigel Pharmaceuticals Balance Sheet (2010-2026) | RIGL

Create an account

Sign In

Reset Password